1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. "We continue to believe macro concerns dissipate," analysts said. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
March 03, 2025 14:21 ET (19:21 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.